183 related articles for article (PubMed ID: 35069414)
41. Deep grey matter iron accumulation in alcohol use disorder.
Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
[TBL] [Abstract][Full Text] [Related]
42. Alterations of Iron Level in the Bilateral Basal Ganglia Region in Patients With Middle Cerebral Artery Occlusion.
Du L; Zhao Z; Liu X; Chen Y; Gao W; Wang Y; Liu J; Liu B; Ma G
Front Neurosci; 2020; 14():608058. PubMed ID: 33551726
[No Abstract] [Full Text] [Related]
43. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder.
Sun J; Lai Z; Ma J; Gao L; Chen M; Chen J; Fang J; Fan Y; Bao Y; Zhang D; Chan P; Yang Q; Ye C; Wu T; Ma T
Mov Disord; 2020 Mar; 35(3):478-485. PubMed ID: 31846123
[TBL] [Abstract][Full Text] [Related]
44. Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study.
Chen J; Cai T; Li Y; Chi J; Rong S; He C; Li X; Zhang P; Wang L; Zhang Y
Quant Imaging Med Surg; 2020 Nov; 10(11):2168-2176. PubMed ID: 33139996
[TBL] [Abstract][Full Text] [Related]
45. Quantifying iron deposition in the cerebellar subtype of multiple system atrophy and spinocerebellar ataxia type 6 by quantitative susceptibility mapping.
Sugiyama A; Sato N; Kimura Y; Fujii H; Maikusa N; Shigemoto Y; Suzuki F; Morimoto E; Koide K; Takahashi Y; Matsuda H; Kuwabara S
J Neurol Sci; 2019 Dec; 407():116525. PubMed ID: 31639532
[TBL] [Abstract][Full Text] [Related]
46. Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T
Lee S; Nam Y; Jang J; Na GH; Kim DG; Shin NY; Choi HS; Jung SL; Ahn KJ; Kim BS
J Magn Reson Imaging; 2018 May; 47(5):1342-1349. PubMed ID: 28815906
[TBL] [Abstract][Full Text] [Related]
47. Characterizing brain iron deposition in subcortical ischemic vascular dementia using susceptibility-weighted imaging: An in vivo MR study.
Liu C; Li C; Yang J; Gui L; Zhao L; Evans AC; Yin X; Wang J
Behav Brain Res; 2015 Jul; 288():33-8. PubMed ID: 25862942
[TBL] [Abstract][Full Text] [Related]
48. Quantitative susceptibility mapping in amyotrophic lateral sclerosis: automatic quantification of the magnetic susceptibility in the subcortical nuclei.
Ghaderi S; Fatehi F; Kalra S; Mohammadi S; Batouli SAH
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Jul; ():1-12. PubMed ID: 38957123
[No Abstract] [Full Text] [Related]
49. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
50. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
[TBL] [Abstract][Full Text] [Related]
51. Developmental trajectory of magnetic susceptibility in the healthy rhesus macaque brain.
Wu J; Peng S; Zhang Y; Pan B; Chen H; Hu X; Gong NJ
NMR Biomed; 2022 Sep; 35(9):e4750. PubMed ID: 35474524
[TBL] [Abstract][Full Text] [Related]
52. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
[TBL] [Abstract][Full Text] [Related]
53. Analysis of deep grey nuclei susceptibility in early childhood: a quantitative susceptibility mapping and R2* study at 3 Tesla.
Raab P; Ropele S; Bültmann E; Salcher R; Lanfermann H; Wattjes MP
Neuroradiology; 2022 May; 64(5):1021-1031. PubMed ID: 34787698
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
[TBL] [Abstract][Full Text] [Related]
55. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of deep gray matter for early brain development using quantitative susceptibility mapping.
Otani S; Fushimi Y; Iwanaga K; Tomotaki S; Shimotsuma T; Nakajima S; Sakata A; Okuchi S; Hinoda T; Wicaksono KP; Takita J; Kawai M; Nakamoto Y
Eur Radiol; 2023 Jun; 33(6):4488-4499. PubMed ID: 36418626
[TBL] [Abstract][Full Text] [Related]
57. Changes in brain iron concentration after exposure to high-altitude hypoxia measured by quantitative susceptibility mapping.
Chen L; Cai C; Yang T; Lin J; Cai S; Zhang J; Chen Z
Neuroimage; 2017 Feb; 147():488-499. PubMed ID: 27986608
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis.
Lancione M; Cencini M; Costagli M; Donatelli G; Tosetti M; Giannini G; Zangaglia R; Calandra-Buonaura G; Pacchetti C; Cortelli P; Cosottini M
Neuroimage Clin; 2022; 34():102989. PubMed ID: 35303599
[TBL] [Abstract][Full Text] [Related]
59. Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.
Chai C; Zhang M; Long M; Chu Z; Wang T; Wang L; Guo Y; Yan S; Haacke EM; Shen W; Xia S
Metab Brain Dis; 2015 Aug; 30(4):1009-16. PubMed ID: 25796223
[TBL] [Abstract][Full Text] [Related]
60. Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease.
Chen Y; Ge M; Kang JJ; Ding YC; Chen YC; Jia ZZ
AJNR Am J Neuroradiol; 2023 Apr; 44(4):410-416. PubMed ID: 36958800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
